Neuro-Oncology Reviews
Volume
27 Number 29
20 October 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 29, 20 October
Ahamed C, Nguyen L, Brock CS, Farzamnia A, Millet P, Sato K, Kumar
KK.
Targeting the tumor
microenvironment in pediatric gliomas: Advances and future
directions in immunotherapy.
Neurooncol
Adv. 2025 Sep 1;7(1):vdaf193. doi:
10.1093/noajnl/vdaf193. PMID:
41030523. Review. ˍ
Serventi JN, Newton HB.
Tumor Treating
Fields: An Innovative Therapy for Glioblastoma and Other Solid
Tumors.
J
Adv Pract Oncol. 2025 Sep 1;16(5):181-191. doi:
10.6004/jadpro.2025.16.5.3. PMID:
41041265. Review. ˍ
Kazda T, Hnidakova L, Minniti G.
Reirradiation
in recurrent glioblastoma.
Curr
Opin Oncol. 2025 Sep 3;37(6):580-588. doi:
10.1097/CCO.0000000000001192. PMID:
41057143. Review.. ˍ
ˍ
Seyve A, Ducray F.
Open questions on
vorasidenib.
Curr
Opin Oncol. 2025 Sep 12;37(6):589-594. doi:
10.1097/CCO.0000000000001193. PMID:
41029964. Perspective˰
ˍ
Hernandez MALU, Apor ADAO, Chan KIP, Khu KJO.
Top
100 Most Cited Articles on Awake Glioma Surgery: A Bibliometric
Analysis.
Acta
Med Philipp. 2025 Sep 16;59(13):60-69. doi:
10.47895/amp.v59i13.11080. PMID:
41104057 Bibliometric analysis. ˍ
Liu S, Liang R.
Oncolytic Virotherapy
for Glioma: A Bibliometric Roadmap for Multidisciplinary Clinical
and Research Strategies.
J
Multidiscip Healthc. 2025 Sep 26;18:6167-6185. doi:
10.2147/JMDH.S557248. PMID:
41040426. Bibliometric analysis. ˍ
Pan XH, Wang N, He YC, Su J, Gao YF.
Scientometric
analysis of glioblastoma and blood-brain barrier research
(1995-2024): evolving trends and therapeutic challenges.
Front
Oncol. 2025 Sep 25;15:1649414. doi:
10.3389/fonc.2025.1649414. PMID:
41079104. Bibliometric analysis. ˍ
Scarpitta R, Cappello E, Cangialosi A, Gori V, Luca G, Gori G,
Bocci G.
Pharmacological Phase I
Clinical Trials in Pediatric Brain Tumors (1990-2024): A
Historical Perspective.
Oncol
Res. 2025 Sep 26;33(10):2603-2656. doi:
10.32604/or.2025.066260. PMID:
41050069. Review.
ˍ
Schurr A.
Glioma neuron symbiosis: a
hypothesis.
Front
Neurosci. 2025 Sep 30;19:1646148. doi:
10.3389/fnins.2025.1646148. PMID:
41098857. Perspective. ˍ
Lang F, Yang C.
Targeting cell cycle
checkpoints for glioma therapy.
Pharmacol
Ther. 2025 Oct 1;275:108932. doi:
10.1016/j.pharmthera.2025.108932. PMID:
41043693. Review˰
ˍ
Sharma A, Boyce Kennedy L, Van Swearingen AED, Ahluwalia MS,
Bagley SJ, Chiang VL, Chung C, Cittelly DM, Daras M, Davies MA,
Fecci PE, Haas-Kogan DA, Hattangadi-Gluth JA, Jerzak KJ, Kim MM,
Malani R, Mehta MP, Moss NS, Neman J, Nguyen DX, Priceman SJ,
Sahebjam S, Shih HA, Soffietti R, Wang N, Zimmer A, Goldberg S,
Khasraw M, Anders CK, Lin NU; SNO/ASCO Brain Metastasis
Collaborative Think Tanks.
Intracranial
metastases from solid tumors: Call to Action and Consensus from
the Society for Neuro-Oncology and American Society of Clinical
Oncology Collaborative.
Neuro
Oncol. 2025 Oct 1:noaf226. doi:
10.1093/neuonc/noaf226. PMID:
41051254. Guidelines. ˍ
Yan S, Zhu X, Xiao Y.
CD70-targeted
CAR-T/NK therapy: Rationale, advances, and future directions.
Transl
Oncol. 2025 Oct 2;62:102555. doi:
10.1016/j.tranon.2025.102555. PMID:
41043320. Review.
ˍ
Bunse L, Bunse T, Kilian M, Quintana FJ, Platten M.
The
immunology of brain tumors.
Sci
Immunol. 2025 Oct 3;10(112):eads0449. doi:
10.1126/sciimmunol.ads0449. PMID:
41042911. Review.
ˍ
Mahdi J, Trivedi V, Monje M.
The
promise of immunotherapy for central nervous system tumours.
Nat
Rev Immunol. 2025 Oct 6. doi:
10.1038/s41577-025-01227-5. PMID:
41053233. Review˰
ˍ
Guo S, Fan X, Li W, Bao J, Ma E, Jin H.
Correlation
between allergy and cancer: a systematic review and meta-analysis.
Sci
Rep. 2025 Oct 7;15(1):34901. doi:
10.1038/s41598-025-18646-y. PMID:
41057446. Review; Meta-analysis. ˍ
Li J, Shao T, Kou J, Ni L.
Male-origin
microchimerism and risk of cancer: a systematic review and
meta-analysis.
BMC
Cancer. 2025 Oct 7;25(1):1528. doi:
10.1186/s12885-025-14860-z. PMID:
41057800. Review; Meta-analysis. ˍ
Singh S, Mohapatra I, Barik D, Zheng H, Kim S, Sharma M, Chen CC,
Singh G.
Harnessing ferroptosis to
transform glioblastoma therapy and surmount treatment resistance.
Cell
Death Discov. 2025 Oct 7;11(1):448. doi:
10.1038/s41420-025-02744-x. PMID:
41057317. Review.
ˍ
Li J, Ross JL, Hambardzumyan D, Brat DJ.
Immunopathology
of Glioblastoma.
Annu
Rev Pathol. 2025 Oct 8. doi:
10.1146/annurev-pathmechdis-042524-025950. PMID:
41061166. Review˰
ˍ
Jiang Z, Xu Y, Nie H, Xu B, Ji N, Zhao Z, Zhang W.
Evidence-based
recommendations for adult high-grade glioma therapy: a critical
appraisal of clinical practice guidelines.
Neurosurg
Rev. 2025 Oct 13;48(1):698. doi:
10.1007/s10143-025-03885-4. PMID:
41081963. Guidelines˰
ˍ
Claude L, Bouter J, Goudjil F, Jouglar E, Martin V, Ollivier L,
Cantaloube M, Padovani L, Laprie A; Groupe français de
radiothérapie pédiatrique (the French group of
paediatric radiotherapy).
Guide for
paediatric radiotherapy procedures: 2025 update.
Cancer
Radiother. 2025 Oct 14;29(7-8):104756. doi:
10.1016/j.canrad.2025.104756. PMID:
41092503. Guidelines˰
ˍ
Barthel FP.
Uncommon Territory: The
Clinical and Molecular Profile of Metastatic Gliomas.
Neuro
Oncol. 2025 Oct 15:noaf244. doi:
10.1093/neuonc/noaf244. PMID:
41092320. Editorial˰
ˍ
Zhang T, Wu X, Hu F, Pan Y, Zhang R, Cheng F, Zhou H, Shi H.
Current Research Progress in
Cranioplasty and Related Repair Materials.
J
Craniofac Surg. 2025 Oct 15. doi:
10.1097/SCS.0000000000012073. PMID:
41091938. Review˰
ˍ
Velammal PNKP, Dhasakeerthi T, Varghese JR, Agrawal M, Veluswami
K, Manickavelan HV, Srinivasan G.
The
effect of oncolytic virotherapy on pediatric brain tumor- a
systematic review.
Childs
Nerv Syst. 2025 Oct 18;41(1):315. doi:
10.1007/s00381-025-06981-4. PMID:
41108331. Review˰
ˍ